Durham's Parion inks deal that could exceed $1 billion

Durham drug developer Parion Sciences reached a licensing deal with Boston-based Vertex Pharmaceuticals, for a possible cystic fibrosis treatment. Licensing could bring the company upwards of $1 billion.